info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Review ArticleOpen Access

Silver Nanoparticle for Disease Treatment: A Review Volume 49 - Issue 1

Girum Tefera Belachew*

  • Department of Biotechnology, College of Natural and Computational Sciences, Debre Birhan University, P.O. Box 445, Debre Birhan, Ethiopia

Received: February 18, 2023;   Published: March 02, 2023

*Corresponding author: Girum Tefera Belachew, Department of Biotechnology, College of Natural and Computational Sciences, Debre Birhan University, P.O. Box 445, Debre Birhan, Ethiopia

DOI: 10.26717/BJSTR.2023.49.007739

Abstract PDF

Abstract

Background: Since nanotechnology may be applied almost everywhere, it is a rapidly developing field of medical science. The need for silver nanoparticles (AgNPs) is rising quickly in numerous industries, including medicine, pharmaceuticals, healthcare, food and beverage, consumer goods, cosmetics, etc. Due to its many applications, including its antibacterial qualities, it has been utilized in home products, medical equipment, food industry, wound dressing, in diagnostic, orthopaedics, and as an anticancer agent. The use of Phyto-constituents in the synthesis of green silver nanoparticles (AgNPs), which have significant promise for treating a variety of ailments, is valuable and encouraging. The synthesis, characterization, and therapeutic potential of silver nanoparticles are discussed in general terms in this review.

Keywords: Silver Nanoparticles; Cytotoxicity; Antiviral Effect; Antibacterial Agent, Anticancer Agent

Introduction

The development of nanotechnology, which offers incredible ways to cope with life-threatening ailments, has boosted advancement in the field of medical science. Nanotechnology is a significant advancement that has numerous uses in a variety of industries, including electronics [1], textiles [2], and most significantly, healthcare [3], where it is used for targeted medication administration, diagnosis, treatment, and biosensing. An extremely appealing platform for a wide range of biological applications is provided by nanoparticles. Treatments using nanoparticles are more precise for diseases like cancer that are challenging to treat. Preventing the killing of non- cancerous cells while harming the tumor cells is the major problem in the treatment of cancer. Oral or parenteral treatments now used circulate throughout the body and are harmful [4].

Just the malignant cells that are actively growing will be targeted for cytotoxicity by targeted medication therapies using nanosized formulations. The use of nanosized formulations in the treatment of chronic diseases like cancer is absolutely astounding [5]. To create vaccinations against the virus, pharmaceutical corporations from across the world are working with researchers. But the world still struggles to accept it. This calls for urgent study and antiviral medicine development to protect human health from life-threatening viruses. Due to their distinctive characteristics and applications, metallic nanoparticles are receiving a lot of attention. The most researched silver nanoparticles are those that have incredibly broad- spectrum activity. Nanoscience research on AgNPs has advanced significantly, particularly in the areas of antimicrobial, antibacterial, antioxidant, antifungal, anti-inflammatory, anti-cancer, and anti-angiogenic properties [6-12]. As a result, the goal of this review paper is to provide an overview of silver nanoparticle therapy.

Synthesis Methods

To produce silver nanostructures, numerous methods have been developed. These approaches can be divided into three categories:

1. Chemical methods [13-16];

2. Physical methods [17-20]; and

3. Biological methods [21-23].

Chemical reduction [13], electrochemical approaches [14], irradiation-assisted chemical methods [15], and pyrolysis [16] are subcategories of chemical methods for the synthesis of silver nanostructures. Metal precursors, reducing agents, and stabilizing/ capping agents are typically the three major components used in the production of silver nanostructures in solution. Boron hydride, sodium citrate, ascorbic acid, alcohol, and hydrazine compounds are some often used reducing agents. In the biological synthesis of AgNPs, benign molecules (proteins, carbohydrates, antioxidants, etc.) produced by living organisms, such as bacteria, fungi, yeasts, and plants, substitute the harmful reducing agents and stabilizers. Many reports have been made about biological techniques based on microorganisms such bacteria [21], fungus [22], and yeast [23]. For the synthesis of AgNP, the less expensive plant systems have been investigated, including lemongrass, Aloe vera, seaweed, alfalfa, tea, neem, mustard, safeda, lotus and tulsi. Enzymatic and nonenzymatic reduction are two possible methods for biological synthesis (e.g., NADPH reductase) [24]. The most popular ecologically friendly production method for AgNP is its synthesis from plant extracts.

Characterization Methods

Numerous characteristics and features of nanoparticles and nanocarriers, including size, shape, morphology, particle size distribution, ultraviolet-visible spectrum (UV-Vis), zeta potential, infrared spectrum, surface area, entrapment efficiency, and drug loading capacity, are frequently observed for characterization purposes [25].

Characterization Methods

Numerous characteristics and features of nanoparticles and nanocarriers, including size, shape, morphology, particle size distribution, ultraviolet-visible spectrum (UV-Vis), zeta potential, infrared spectrum, surface area, entrapment efficiency, and drug loading capacity, are frequently observed for characterization purposes [25].

Therapeutic Effect of Silver Nanoparticle

Antibacterial Effect

Antibacterial activity is defined as the removal of bacteria from the body or the slowing of their growth without harming neighboring cells. Silver is preferred as a nanoparticle because it is non- toxic to humans and possesses antibacterial properties. Ag-NPs can overcome the antibiotic resistance that has existed. AgNPs have been shown to have the potential to operate as an antibacterial agent due to their large surface-to-volume ratio and crystalline surface structure [26]. Several drug-resistant strains can be eliminated by AgNPs, proving that these Ag-NPs have the potential to function as an antibacterial agent [27]. Gram-negative bacteria are known to exhibit greater antibacterial activity than Gram-positive bacteria. It is caused by the presence of a cell wall, or peptidoglycan layer, which is reported to be thick in gram-positive bacteria, measuring 30 nm, whereas it is relatively thin in gram-negative bacteria, measuring only 3-4 nm [28]. Another factor is that cellular membranes are negatively charged, possibly because of the presence of carboxyl, phosphate, and amino groups, as opposed to bacteria, which have positive charges that attract negatively charged objects like AgNPs. This attachment to the cellular membrane will change the antibacterial activity of AgNP [28]. The antibacterial activity of the chitosan-Ag-nanoparticle composite was shown to be stronger than that of its components at their respective concentrations because one-pot synthesis favored the creation of tiny AgNPs connected to the polymer, which can be disseminated in solutions with pH 6.3.

Antiviral Activity

Since viral infections and diseases are widespread throughout the world, it is crucial to develop antiviral medications that have noticeable results. Due to their extremely small size and distinctive shape, AgNPs are seen to be particularly conspicuous in displaying such findings. It has been noted that silver is efficient against viruses and is shown to be largely non-toxic to both humans and animals [29]. HIV AgNPs were discovered to produce acceptable results. In this instance, AgNP functions as an anti-viral at an early stage of viral replication, primarily acting as virucidal or maybe inhibiting viral entry. AgNPs will attach to gp120 and stop CD-4 dependent virion binding and infectivity, acting as a powerful virucidal agent against cell free viruses. In addition to this, AgNPs block the HIV-1 life cycle after entrance [29].

Antifungal Activity

Those with weaker immune systems are more vulnerable to fungus infections. This technique is proven to be particularly timeconsuming in nature when trying to treat fungus-related disorders. The number of antiviral medications on the market is extremely small [30]. Antiviral medications must be non-toxic, biocompatible, and environmentally friendly. Several disorders that are brought on by fungi are discovered to be particularly susceptible to AgNPs [31]. Bipolaris sorokiniana was effectively combatted by biologically produced AgNPs by preventing conidial germination. AgNPs also suppress indoor fungal species, including those grown on agar media such as Penicillium brevicompactum, Aspergillus fumigatus, Cladosporium cladosporoides, Chaetomium globosum, Stachybotrys chartarum, and Mortierella alpine.

Anticancer Activity

Cancer is essentially an unchecked cell proliferation in a specific bodily location. Almost one in three people worldwide have some form of cancer. For cancer patients, there are numerous therapies available, such as chemotherapy and radiation therapy, but they all have severe side effects and a painful recovery period. It is commonly known that chemotherapy, surgery, and radiation therapy are all used in the treatment of cancer. Targeted therapy is also quite costly and uncomfortable [31]. Finding efficient, affordable, and sensitive molecules is therefore necessary for the therapy of cancer. Several studies have been conducted to learn more about the promising outcomes of AgNPs [32]. It is seen to be the best option for treating cancer and a substitute for other cancer therapies. Only by encapsulating the therapeutic ingredient in a nanoparticle and using it as a medication delivery system do they have the potential to target specific cells or tumors at that location. A549 cells displayed 21% and 73% viability after 6 hours of exposure to the produced AgNPs from Albizia adianthifolia leaf extract (AA-AgNPs), whereas normal peripheral lymphocytes displayed 117 and 109 percent viability.

This proves that normal PLs cells are not harmed by AgNPs. A549 cells were 50% more inhibited at 43 g/mL of AA-AgNPs, and apoptosis, which is caused by the production of ROS, was also increased. Sesbania grandiflora-mediated AgNPs (20 g/mL)-treated MCF-7 cells exhibit nuclear condensation, cell shrinkage, and fragmentation after 48 hours of Hoechst staining. These modifications imply that the cleavage has made it possible to perform DNA repair [31,32-53] (Table 1 & Figure 1).

Table 1: Medicinal value of silver nanoparticle as per published literature.

biomedres-openaccess-journal-bjstr

Figure 1: Biomedical applications of silver nanoparticles [53].

biomedres-openaccess-journal-bjstr

Conclusion

As silver nanoparticles have so many applications across so many industries, they are now widely employed. In addition to its extensive use as an antibacterial, Ag-NPs also have applications in gene therapy, anti-inflammatory medicine, anti-fungal medicine, diagnostic imaging, and many other fields. AgNPs are currently being researched as a potential cancer therapy alternative to other traditional treatments like chemotherapy, radiation therapy, etc. One of the intriguing methods for treating cancer is the use of these AgNPs as an antiangiogenic. There are three ways to make these AgNPs: physically, chemically, and biologically. The most popular method among the three is biological because it is safe for the environment, non-toxic, and eco-friendly. In the case of cancer treatment, it has been determined to be secure and site- specific. We can therefore conclude that these AgNPs are effective, simple, and safe treatments for a variety of disorders.

Data Availability

All of the required data will be available upon request to the corresponding author.

Authors’ Contributions

The author wrote the paper alone.

Acknowledgment

The author is grateful to thank those individuals who gave help directly or indirectly.

Financial Support and Sponsorship

There is no financial support and sponsorship.

Conflicts of Interest

There are no conflicts of interest.

References

  1. Balantrapu K, Goia DV (2009) Silver nanoparticles for printable electronics and biological applications. J Mat Res 24(09): 2828-2836.
  2. Hasan KMF, Pervez MN, Talukder ME, Sultana MZ, Mahmud S, et al. (2019) A novel coloration of polyester fabric through green silver nanoparticles (G- AgNPs@PET). Nanomaterials 9(4): 569.
  3. Burdusel AC, Gherasim O, Grumezescu AM, Mogoanta L, Ficai A, et al. (2019) Biomedical applications of silver nanoparticles: an up-to-date overview. Mol 24: 719.
  4. Karmous I, Pandey A, Ben K, Haj KB, Chaoui A (2020) Efficiency of the green synthesized nanoparticles as new tools in cancer therapy: insights on plant-based bioengineered nanoparticles, biophysical properties, and anticancer roles. Bio Tra Ele Res 196: 330-342.
  5. Yesilot S, Aydin C (2019) Silver nanoparticles; a new hope in cancer therapy? East J Med 24(1): 111-116.
  6. Sondi I, Sondi BS (2004) Silver nanoparticles as antimicrobial agent: a case study on coli as a model for Gram-negative bacteria. J Col and Inter Sci 275: 177-182.
  7. Nagarajan S, Kalaivani G, Poongothai E, Arul M, Natarajan H (2019) Characterization of silver nanoparticles synthesized from Catharanthus roseus (Vinca rosea) plant leaf extract and their antibacterial activity. IJRAR 6(1): 680-685.
  8. Al-Shmgani HSA, Mohammed WH, Sulaiman GM, Saadoon AH (2017) Biosynthesis of Silver nanoparticles from Catharanthus roseus leaf extract and assessing their antioxidant, antimicrobial, and woundhealing activities. Art Cell Nanomed Biotech 45(6): 1234-1240.
  9. Deya C, Bellotti N (2017) Biosynthesized silver nanoparticles to control fungal infections in indoor environments. Adv Nat Sci Nanosci Nanotechnol 8: 1-8.
  10. Singh P, Ahn S, Kang JP, Veronika S, Huo Y, et al. (2018) In vitro anti-inflammatory activity of spherical silver nanoparticles and monodisperse hexagonal gold nanoparticles by fruit extract of Prunus serrulata: a green synthetic approach. Artific Cells Nanomed Biotechnol 46(8): 2022-2032.
  11. Yuan YG, Zhang S, Hwang JY, Kong IK (2018) Silver nanoparticles potentiates cytotoxicity and apoptotic potential of camptothecin in human cervical cancer cells. Oxida Medi Cellu Longe 1: 1-21.
  12. Kalishwaralal K, Banumathi E, Pandian SRK, Deepak V, Muniyandi J, et al. (2009) Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Coll and Surf B: Biointer 73: 51-57.
  13. Zhang Q, Na Li, James Goebl, Zhenda Lu, Yadong Yin (2011) A systematic study of the synthesis of silver nanoplates: is aitrate a ‘magic’ reagent. J Am Chem Soc 133: 18931-18939.
  14. Roldán MV, Nora Pellegri, Oscar de Sanctis (2013) Electrochemical method for Ag-PEG nanoparticles synthesis. J Nanopart 2013: 7.
  15. Sotiriou GA, Pratsinis SE (2010) Antibacterial activity of nanosilver ions and particles. Environ Sci Technol 44: 5649-5654.
  16. Sotiriou GA, Alexandra Teleki, Adrian Camenzind, Frank Krumeich, Andreas Meyer, et al. (2011) Nanosilver on nanostructured silica: antibacterial activity and Ag surface area. Chem Eng J 170: 547-554.
  17. Kholoud MM, Alaa Eftaiha, Abdulrhman Al-Warthan, Reda AA Ammar (2010) Synthesis and applications of silver nanoparticles. Arab J Chem 3: 135-140.
  18. Tien D, Kuo-Hsiung Tseng, Chih-Yu Liao, Jen-Chuen Huang, Tsing-Tshih Tsung (2008) Discovery of ionic silver in silver nanoparticle suspension fabricated by arc discharge method. J Alloys Compounds 463: 408-411.
  19. Kosmala A, R Wright, Q Zhang, P Kirby (2011) Synthesis of silver nano particles and fabrication of aqueous Ag inks for inkjet printing. Mater Chem Phys 129: 1075-1080.
  20. Asanithi P, S Chaiyakun, P Limsuwan (2012) Growth of silver nanoparticles by DC magnetron sputtering. J Nanomater 2012: 8.
  21. Shivaji S, S Madhu, Shashi Singh (2011) Extracellular synthesis of antibacterial silver nanoparticles using psychrophilic bacteria. Process Biochem 46: 1800-1807.
  22. Li G, Dan He, Yongqing Qian, Buyuan Guan, Song Gao, et al. (2012) Fungus-mediated green synthesis of silver nanoparticles using Aspergillus terreus. Int J Mol Sci 13: 466-476.
  23. Mourato A, Mário Gadanho, Ana R Lino, Rogério Tenreiro (2011) Biosynthesis of crystalline silver and gold nanoparticles by extremophilic yeasts. Bioinorg Chem Appl 2011: 8.
  24. Ge L, Qingtao Li, Meng Wang, Jun Ouyang, Xiaojian Li, et al. (2014) Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int J Nanomed 9: 2399-2407.
  25. Mukherji S, Bharti S, Shukla G, Mukherji S (2018) Synthesis and characterization of size- and shape-controlled silver nanoparticles. Phys Sci Rev 4(1).
  26. Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73: 1712-1720.
  27. Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI (2005) Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 5: 244-249.
  28. Kvítek L, Panáček A, Soukupova J, Kolář M, Večeřová R, et al. (2008) Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem 112: 5825-5834.
  29. Trefry JC, Wooley DP (2013) Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis- dependent mechanism. J Biomed Nanotechnol 9: 1624-1635.
  30. Kim KJ, Sung WS, Moon SK, Choi JS, Kim JG, et al. (2008) Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol 18: 1482-1484.
  31. Gurunathan S, Han JW, Kim ES, Park JH, Kim JH (2015) Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule. Int J Nanomedicine 10: 2951-2969.
  32. Sriram MI, Kanth SB, Kalishwaralal K, Gurunathan S (2010) Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model. Int J Nanomedicine 5: 753-762.
  33. Sivakumar J, Suresh S, Zin T, US MR (2021) Antidiabetic potential and high synergistic antibacterial activity of silver nanoparticles synthesised with Musa Paradisiaca tepal extract. The Medical Journal of Malaysia 76(1): 80-86.
  34. Hussein J, El-Naggar ME, Fouda MM, Morsy OM, Ajarem JS, et al. (2020) The efficiency of blackberry loaded AgNPs, AuNPs and Ag@ AuNPs mediated pectin in the treatment of cisplatin-induced cardiotoxicity in experimental rats. International Journal of Biological Macromolecules 159: 1084-1093.
  35. Yang Y, Song W, Chen Z, Li Q, Liu L (2019) Ameliorative effect of synthesized silver nanoparticles by green route method from Zingiber zerumbet on mycoplasmal pneumonia in experimental mice. Artificial Cells, Nanomedicine, and Biotechnology 47(1): 2146-2154.
  36. Moghanlo H, Shariatzadeh SM (2022) Beneficial effects of Spirulina platensis on mice testis damaged by silver nanoparticles. Andrologia 54(11): e14606.
  37. Ferreira LA, Garcia Fossa F, Radaic A, Duran N, Favaro WJ, et al. (2020) Biogenic silver nanoparticles: In vitro and in vivo antitumor activity in bladder cancer. European Journal of Pharmaceutics and Biopharmaceutics 151: 162-170.
  38. Karunakaran S, Hari R (2022) Comparative Antioxidant and Anti-gout Activities of Citrullus colocynthis loaded Fruit Silver nanoparticles with its Ethanolic extract. Avicenna Journal of Medical Biotechnology 14(4): 303-309.
  39. Konop M, Czuwara J, Kłodzińska E, Laskowska AK, Sulejczak D, et al. (2020) Evaluation of keratin biomaterial containing silver nanoparticles as a potential wound dressing in full‐thickness skin wound model in diabetic mice. Journal of tissue engineering and regenerative medicine 14(2): 334-346.
  40. Chandrasekaran R, Seetharaman P, Krishnan M, Gnanasekar S, Sivaperumal S (2018) Carica papaya (Papaya) latex: a new paradigm to combat against dengue and filariasis vectors Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae). 3 Biotech 8: 1-10.
  41. Nandi SK, Shivaram A, Bose S, Bandyopadhyay A (2018) Silver nanoparticle deposited implants to treat osteomyelitis. Journal of Biomedical Materials Research Part B: Applied Biomaterials 106(3): 1073-1083.
  42. Said DE, Elsamad LM, Gohar YM (2012) Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents. Parasitology research 111: 545-554.
  43. Pourmobini H, Arababadi MK, Salahshoor MR, Roshankhah S, Taghavi MM, et al. (2021) The effect of royal jelly and silver nanoparticles on liver and kidney inflammation. Avicenna journal of phytomedicine 11(3): 218.
  44. Reshi MS, Yadav D, Uthra C, Shrivastava S, Shukla S (2020) Acetaminophen-induced renal toxicity: preventive effect of silver nanoparticles. Toxicology Research 9(4): 406-412.
  45. Morris D, Ansar M, Speshock J, Ivanciuc T, Qu Y, et al. (2019) Antiviral and immunomodulatory activity of silver nanoparticles in experimental RSV infection. Viruses 11(8): 732.
  46. Rashid M, Or M, Ferdous J, Banik S, Islam M, et al. (2016) Anthelmintic activity of silver-extract nanoparticles synthesized from the combination of silver nanoparticles and M. charantia fruit extract. BMC Complementary and Alternative Medicine 16(1): 1-6.
  47. Mohamed DS, Abd El-Baky RM, Sandle T, Mandour SA, Ahmed EF (2020) Antimicrobial activity of silver-treated bacteria against other multi-drug resistant pathogens in their environment. Antibiotics 9(4): 181.
  48. Heshmati M, ArbabiBidgoli S, Khoei S, Rezayat SM, Parivar K (2015) Mutagenic effects of nanosilver consumer products: a new approach to physicochemical properties. Iranian journal of pharmaceutical research: IJPR 14(4): 1171.
  49. Jackson K, Devaraj E, Lakshmi T, Rajeshkumar S, Dua K, et al. (2020) Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells. Bioinformation 16(11): 817.
  50. Hussaina Banu, N Renuka, SM Faheem, Raees Ismail, Vinita Singh, et al. (2018) Gold and Silver Nanoparticles Biomimetically Synthesized Using Date Palm Pollen Extract- Induce Apoptosis and Regulate p53 and Bcl-2 Expression in Human Breast Adenocarcinoma Cells. Biol Trace Elem Res 186(1): 122-134.
  51. Sharma RK, Cwiklinski K, Aalinkeel R, Reynolds JL, Sykes DE, et al. (2017) Immunomodulatory activities of curcumin-stabilized silver nanoparticles: Efficacy as an antiretroviral therapeutic. Immunological investigations 46(8): 833-846.
  52. Guo D, Zhang J, Huang Z, Jiang S, Gu N (2015) Colloidal silver nanoparticles improve anti-leukemic drug efficacy via amplification of oxidative stress. Colloids and Surfaces B: Biointerfaces 126: 198-203.
  53. Hussain Z, Abourehab MA, Khan S, Thu HE (2020) Silver nanoparticles: A promising nanoplatform for targeted delivery of therapeutics and optimized therapeutic efficacy. InMetal Nanoparticles for Drug Delivery and Diagnostic Applications pp. 141-173.